VERTEX PHARMACEUTICALS INC / MA·4

May 18, 4:18 PM ET

Liu Joy 4

4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 18, 2022

Insider Transaction Report

Form 4
Period: 2022-05-16
Liu Joy
EVP and Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2022-05-16$250.77/sh25$6,26914,442 total
  • Sale

    Common Stock

    2022-05-16$254.36/sh35$8,90314,334 total
  • Sale

    Common Stock

    2022-05-16$251.57/sh19$4,78014,423 total
  • Sale

    Common Stock

    2022-05-16$252.49/sh20$5,05014,403 total
  • Sale

    Common Stock

    2022-05-16$253.87/sh34$8,63214,369 total
Footnotes (7)
  • [F1]Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
  • [F2]Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
  • [F3]Open market sales reported on this line occurred at a weighted average price of $250.77 (range $250.00 to $250.90).
  • [F4]Open market sales reported on this line occurred at a weighted average price of $251.57 (range $251.05 to $251.81).
  • [F5]Open market sales reported on this line occurred at a weighted average price of $252.49 (range $252.12 to $253.11).
  • [F6]Open market sales reported on this line occurred at a weighted average price of $253.87 (range $253.14 to $254.13).
  • [F7]Open market sales reported on this line occurred at a weighted average price of $254.36 (range $254.15 to $254.57).

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION